期刊文献+

血管形成拟态在肿瘤中的研究进展 被引量:7

Research progress in vasculogenic mimicry in multiple tumors
下载PDF
导出
摘要 血管生成拟态(vasculogenic mimicry,VM)是指肿瘤中的脉管系统不依赖血管形成,肿瘤细胞具有形成供血管状网络的能力,从而为肿瘤的生长提供丰富的血供模式。VM的形成包括多种分子机制和信号通路,在其形成过程中还发现肿瘤干细胞和上皮-间充质转变。作为一种独特的血供方式,VM与肿瘤细胞的浸润、转移和晚期癌症患者预后密切相关,靶向VM的抗癌疗法将会成为一种新的肿瘤治疗策略。 Vasculogenic mimicry (VM) is a brand-new tumor vascular pattern with the ability to form vessel- like networks without participation of endothelial cells and independent on angiogenesis. It can provide adequate blood supply for tumor growth. The formation of VM involves multiple molecule mechanisms and signal pathways, including cancer stem cell and epithelial-mesenchymal transition. As a unique blood-supply pattern, VM is associated with cancer invasion, metastasis and poor prognosis. Because of its important role in cancer progression, VM will become a new target for therapy of cancers.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2017年第3期357-364,共8页 Journal of Central South University :Medical Science
关键词 血管生成拟态 肿瘤 信号通路 肿瘤治疗 vasculogenic mimicry cancer signal pathways therapy
  • 相关文献

参考文献9

二级参考文献79

  • 1范跃祖,孙伟,张文忠,葛春艳.原发性胆囊癌患者肿瘤血管生成拟态及其临床意义[J].中华医学杂志,2007,87(3):145-149. 被引量:30
  • 2赵静,黄江生,杨爱军,王晨昱,刘伟,李敏.肝细胞癌中血管生成拟态的三维细胞培养及组织学研究[J].癌症,2007,26(2):123-126. 被引量:24
  • 3Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature, 2011,474:609-615.
  • 4Bowtell DD. The genesis and evolution of high-grade serous ovarian cancer. Nat Rev Cancer, 2010,10:803-808.
  • 5Kurman RJ, Shih leM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol, 2011,42:918-931.
  • 6Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov, 2012,2:401-404.
  • 7Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal,2013,6:pI1.
  • 8Zorn KK, Bonome T, Gangi L, et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res, 2005,11 :6422-6430.
  • 9Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene, 2005,24:7455-7464.
  • 10Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer, 2009,9:550-562.

共引文献138

同被引文献43

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部